Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $33.1 million.

  • NeuroPace's Shares Outstanding (Diluted Average) rose 1253.19% to $33.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.1 million, marking a year-over-year increase of 1253.19%. This contributed to the annual value of $29.1 million for FY2024, which is 1266.64% up from last year.
  • As of Q3 2025, NeuroPace's Shares Outstanding (Diluted Average) stood at $33.1 million, which was up 1253.19% from $32.9 million recorded in Q2 2025.
  • NeuroPace's Shares Outstanding (Diluted Average)'s 5-year high stood at $33.1 million during Q3 2025, with a 5-year trough of $269178.0 in Q1 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $24.9 million, with a median of $25.5 million in 2023.
  • As far as peak fluctuations go, NeuroPace's Shares Outstanding (Diluted Average) skyrocketed by 1180733.52% in 2021, and later soared by 260.28% in 2022.
  • NeuroPace's Shares Outstanding (Diluted Average) (Quarter) stood at $16.6 million in 2021, then soared by 48.08% to $24.6 million in 2022, then rose by 5.11% to $25.9 million in 2023, then increased by 12.67% to $29.1 million in 2024, then increased by 13.76% to $33.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $33.1 million for Q3 2025, versus $32.9 million for Q2 2025 and $31.5 million for Q1 2025.